Automated Container Closure Integrity Inspection System for Parenteral Products

Cytiva will combine its CGT manufacturing technologies with Cellular Origins' robotic manufacturing platform.

This episode is a compilation of comments taken from a series of interviews where experts are discussing how AI might impact the global bio/pharma industry in the future.

The two companies will be exhibiting together after Gerresheimer’s December 2024 acquisition of Bormioli.

In this podcast episode, we discuss trends in dosage forms, specifically oral solid dosage, as viewed by five industry experts who recently exhibited at CPHI Milan.

This investment is additional to and separate from £11 million that was announced in the fall of 2024 for creating new jobs and expanding Almac’s global analytical services capabilities.

Pharmapack identifies biologic approvals, drug delivery advancements, GLP-1 generics, and the return of funding flow as drivers for a record year in 2025.